Jeremy Luban to Molecular Targeted Therapy
This is a "connection" page, showing publications Jeremy Luban has written about Molecular Targeted Therapy.
Connection Strength
0.045
-
Lechner K, Mott S, Al-Saifi R, Knipfer L, Wirtz S, Atreya R, Vieth M, Rath T, Fraass T, Winter Z, August A, Luban J, Zimmermann VS, Weigmann B, Neurath MF. Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis. Gastroenterology. 2021 10; 161(4):1270-1287.e19.
Score: 0.045